US SEC Filings Daily Market Digest — February 25, 2026

26-02-2026

BioLife Solutions Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001628280-26-012264, Size: 681 KB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned in the provided filing description. This is a standard voluntary earnings-related disclosure without detailed performance data.

26-02-2026

Autodesk, Inc. filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details, period-over-period comparisons, or forward-looking statements are mentioned.

26-02-2026

TeraWulf Inc. filed an 8-K on February 26, 2026 (AccNo: 0001083301-26-000026), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are explicitly stated in the provided filing information.

26-02-2026

Nautilus Biotechnology, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001808805-26-000004) disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

26-02-2026

Titan International Inc filed an 8-K on February 26, 2026 (AccNo: 0000899751-26-000009, Size: 632 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing summary.

• ·AccNo: 0000899751-26-000009
• ·File Size: 632 KB
• ·Event Type: Financial Results
• ·Source: us_sec

26-02-2026

Donaldson Co Inc filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data.

26-02-2026

NCR Voyix Corp filed a Form 8-K on February 26, 2026 (AccNo: 0000070866-26-000005), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing announces financial results, but specific revenue, earnings, guidance, or period-over-period comparisons are NOT_DISCLOSED. No quantitative metrics, balance sheet effects, or outlook revisions are provided in the available information.

26-02-2026

Entrada Therapeutics, Inc. filed a Form 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were disclosed in the provided information. This is a multi-item filing focused on financial results announcement.

26-02-2026

Middleby Corp filed an 8-K on February 26, 2026 (AccNo: 0000769520-26-000006), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a standard earnings-related disclosure. No specific financial metrics, period-over-period changes, guidance, or other quantitative details are disclosed in the provided filing information.

26-02-2026

D-Wave Quantum Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001907982-26-000022, Size: 7 MB), under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item voluntary disclosure typical for earnings releases, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative metrics are available for balanced assessment.

26-02-2026

Indivior PLC filed a Form 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.

26-02-2026

The registrant filed a Form 8-K on February 26, 2026 (AccNo: 0001331463-26-000041), reporting under Item 2.03 the creation of a direct financial obligation through a new Credit Agreement effective the same date. No specific dollar amounts, terms, maturity dates, interest rates, covenants, or strategic purposes are disclosed in the provided filing information. This represents a mandatory disclosure of a potentially material financing event, but lacks quantitative details for impact assessment.

26-02-2026

Cronos Group Inc. filed a Form 8-K on 2026-02-26 (AccNo: 0001656472-26-000015, Size: 978 KB) reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, positive metrics, negative metrics, or flat performance details are disclosed. This appears to be a standard voluntary earnings-related disclosure.

• ·AccNo: 0001656472-26-000015
• ·File size: 978 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

26-02-2026

Collegium Pharmaceutical, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001628280-26-011990), under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing announces financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are provided.

26-02-2026

Cheniere Energy, Inc. filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or other quantitative details are provided in the filing summary. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

• ·AccNo: 0000003570-26-000006
• ·Filing size: 575 KB

26-02-2026

Cars.com Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-073457), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were detailed in the provided filing information. This is a standard earnings-related disclosure without quantified metrics.

26-02-2026

Pulmatrix, Inc. filed an 8-K on February 26, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are disclosed in the provided filing information. This appears to be an informational earnings-related disclosure without detailed performance metrics available.

26-02-2026

i-80 Gold Corp. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-075272, size: 236 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, positive or negative changes, guidance, or operational details are explicitly stated in the provided filing information. This appears to be a multi-item voluntary disclosure without quantified impacts.

26-02-2026

Flowco Holdings Inc. filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-073255), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. Sector details are not specified.

26-02-2026

Enovis Corp filed a Form 8-K on February 26, 2026 (AccNo: 0001420800-26-000008, Size: 637 KB), reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. This is a standard earnings-related disclosure for a US equity market company. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing summary.

26-02-2026

International Seaways, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001104659-26-020057), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results in the US equity markets. No specific financial metrics, period-over-period comparisons, or other quantitative details are provided in the available filing information.

26-02-2026

Biocryst Pharmaceuticals Inc. filed a Form 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results with AccNo 0001171843-26-001119 and file size 435 KB. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information.

26-02-2026

26-02-2026

26-02-2026

26-02-2026

Privia Health Group, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached financial statements.

26-02-2026

Fortrea Holdings Inc. filed an 8-K on 2026-02-26 reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

• ·Filing Accession Number: 0001628280-26-011942
• ·Filing Size: 440 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

26-02-2026

Primo Brands Corp filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or strategic details are mentioned.

26-02-2026

BeOne Medicines Ltd. filed an 8-K on February 26, 2026 (AccNo: 0001628280-26-011941), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons were disclosed in the filing summary. The filing size is 2 MB, with sector not specified.

26-02-2026

Arhaus, Inc. filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item voluntary disclosure typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

26-02-2026

Qnity Electronics, Inc. filed a Form 8-K on February 26, 2026, disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard mandatory earnings-related disclosure with attached exhibits.

• ·Filing Accession Number: 0002058873-26-000007
• ·Filing Size: 681 KB
• ·Sector: NOT_DISCLOSED

26-02-2026

First Advantage Corp filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-073071), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No revenue, earnings, margins, guidance, period-over-period changes, or other quantitative financial metrics were explicitly stated in the filing description. This is a standard voluntary disclosure of financial results without detailed data provided.

• ·File size: 1 MB

26-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. Critical event content is missing, limiting assessment of impact.

26-02-2026

Walker & Dunlop, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet effects, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item earnings-related disclosure with no detailed performance data available.

26-02-2026

Norris Industries, Inc. filed an 8-K on February 26, 2026, specifically reporting Item 4.01 Changes in Registrant's Certifying Accountant. No financial metrics, transaction values, reasons for the change, names of prior or new accountants, or other details were disclosed. This represents a single-item mandatory disclosure with no quantified impacts provided.

26-02-2026

InvenTrust Properties Corp. filed an 8-K on February 26, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. The filing size is 6 MB, suggesting possible attachments such as press releases or presentations, but no specific details, financial metrics, transactions, or events are disclosed in the provided information. No positive or negative metrics reported.

26-02-2026

Aurinia Pharmaceuticals Inc. filed an 8-K on 2026-02-26 (AccNo: 0001600620-26-000015, Size: 357 KB) under Item 2.02 disclosing results of operations and financial condition. No quantitative financial metrics, revenue, earnings, guidance, or period-over-period comparisons are mentioned in the provided filing information. Sector is not specified.

26-02-2026

Soleno Therapeutics Inc filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Specific details on the affected position, person involved, appointment or resignation status, reasons, and any quantitative metrics are NOT_DISCLOSED.

26-02-2026

Acushnet Holdings Corp. filed an 8-K on 2026-02-26 reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no detailed performance data available.

26-02-2026

Ecovyst Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001708035-26-000047), reporting under Item 2.02 for Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. This constitutes a multi-item voluntary disclosure of financial results. No specific quantitative financial metrics, comparisons, or details are disclosed in the filing summary provided.

26-02-2026

FRANKLIN ELECTRIC CO INC filed an 8-K on February 26, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. All quantitative and qualitative impacts are NOT_DISCLOSED.

26-02-2026

NexPoint Real Estate Finance, Inc. filed an 8-K on February 26, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided information.

26-02-2026

Celsius Holdings, Inc. filed a Form 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item informational filing typical for earnings releases.

26-02-2026

PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. filed a Form 8-K on February 26, 2026, disclosing changes in its certifying accountant under Item 4.01. The filing also references Item 9.01 for financial statements and exhibits. No quantitative data, financial metrics, named entities beyond the registrant, or further details on the change are explicitly stated.

26-02-2026

News Corp filed a Form 8-K on February 26, 2026, reporting Other Events under Item 8.01 and attaching Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the filing summary. This is a multi-item informational filing with no quantified metrics or directional impacts provided.

26-02-2026

KBR, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001357615-26-000049, Size: 1 MB), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure with no quantified positive or negative performance indicators available.

26-02-2026

Kinetik Holdings Inc. filed an 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the filing summary. This represents a standard mandatory disclosure for financial results without detailed performance data.

26-02-2026

ZIFF DAVIS, INC. filed an 8-K on February 26, 2026, specifically under Item 7.01 for Regulation FD Disclosure, with Accession Number 0001084048-26-000007 and file size of 140 KB. No financial metrics, transaction details, quantitative data, positive or negative performance indicators, scheduled events, or other specific content are disclosed in the provided filing information. This is a single-item voluntary filing with no mentioned market or strategic impacts.

26-02-2026

Clear Channel Outdoor Holdings, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard disclosure for financial results with attached statements. No specific revenue, earnings, guidance, period-over-period changes, or other metrics are disclosed in the provided filing information.

26-02-2026

Cactus, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. Specific details on the affected officer position, name, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the available information.

26-02-2026

Ellington Financial Inc. filed a Form 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, comparisons, or guidance in the available information. No positive, negative, or flat performance indicators are detailed.

26-02-2026

Hormel Foods Corp /DE/ filed an 8-K on February 26, 2026 (AccNo: 0000048465-26-000018), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. Sector is not specified.

• ·Filing size: 541 KB
• ·Event Type: Financial Results
• ·Source: us_sec

26-02-2026

Integra LifeSciences Holdings Corp filed an 8-K on February 26, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits provided under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the filing details provided. This appears to be a standard earnings-related disclosure without detailed performance data available.

26-02-2026

Zura Bio Ltd filed a Form 8-K on 2026-02-26 disclosing entry into a Material Definitive Agreement under Item 1.01, Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01 (AccNo: 0001104659-26-019827, size 744 KB). This is a multi-item filing covering a material transaction alongside financial updates, but specific details including transaction value, financial metrics, and performance changes are NOT_DISCLOSED. No quantitative impacts or period-over-period comparisons are available.

• ·Multi-item 8-K filing
• ·Sector: NOT_DISCLOSED

26-02-2026

VSE Corp filed an 8-K on February 26, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are disclosed in the provided filing summary. This is an informational disclosure of financial results without quantified details.

26-02-2026

Trulieve Cannabis Corp. filed a Form 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item filing typical for earnings releases with no specific revenue, earnings, or other metrics disclosed. No positive, negative, or flat performance indicators are provided in the filing summary.

26-02-2026

International Paper Co /NEW/ filed an 8-K on February 26, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific financial metrics, transactions, events, or quantitative data are explicitly stated in the provided filing information. This is a voluntary disclosure with no details on positive or negative impacts available.

26-02-2026

Carriage Services Inc filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantitative financial metrics available.

26-02-2026

Ducommun Inc./DE/ filed a Form 8-K on February 26, 2026 (AccNo: 0001628280-26-011949, Size: 754 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results with no specific quantitative metrics, period-over-period changes, positive or negative performance indicators disclosed in the provided information. No revenue, earnings, guidance, or balance sheet details are mentioned.

26-02-2026

Certara, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance numbers.

26-02-2026

Nuvalent, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-073304, Size: 378 KB), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

26-02-2026

United Parks & Resorts Inc. filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with exhibits attached.

26-02-2026

Perrigo Co plc filed an 8-K on February 26, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard multi-item voluntary disclosure for financial results with no directional performance indicators available.

26-02-2026

Eos Energy Enterprises, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001628280-26-011958), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information.

26-02-2026

Wolverine World Wide Inc. (/DE/) filed a Form 8-K on February 26, 2026 (AccNo: 0001628280-26-011956, Size: 690 KB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item, voluntary earnings-related filing typical for US public companies. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are provided in the filing description.

26-02-2026

American Bitcoin Corp. filed an 8-K on February 26, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, or period-over-period comparisons are disclosed in the provided filing information. This appears to be an informational disclosure of quarterly or annual results without detailed quantitative data available.

26-02-2026

Warby Parker Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001504776-26-000003), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely announcing quarterly or annual financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

26-02-2026

CommScope Holding Company, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-073295), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard earnings-related disclosure, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED in the provided filing details. No positive or negative performance indicators, period-over-period comparisons, or balance sheet impacts are mentioned.

26-02-2026

Krispy Kreme, Inc. filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

26-02-2026

TopBuild Corp filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other details are disclosed in the provided filing information.

26-02-2026

J M Smucker Co filed an 8-K on February 26, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a multi-item filing with no specific revenue, earnings, guidance, or other quantitative financial metrics disclosed in the provided information. No positive or negative performance details, period-over-period comparisons, or strategic updates are mentioned.

26-02-2026

Nexstar Media Group, Inc. filed an 8-K on 2026-02-26 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No quantitative financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other specific numbers are mentioned in the provided filing details. This is a standard mandatory disclosure for financial results without detailed performance data available.

26-02-2026

Warner Bros. Discovery, Inc. filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely related to an earnings release or financial update. No specific financial metrics, guidance, transaction details, or quantitative data are disclosed in the provided filing summary.

26-02-2026

Kimbell Royalty Partners, LP filed an 8-K on February 26, 2026 (AccNo: 0001104659-26-020066, Size: 500 KB), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for financial results releases. No specific revenue, earnings, comparisons, positive or negative metrics, guidance, or other quantitative details are explicitly stated.

26-02-2026

Frontdoor, Inc. filed an 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are provided in the filing summary. This appears to be a standard earnings-related disclosure with no disclosed positive or negative performance indicators.

26-02-2026

Ligand Pharmaceuticals Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0000886163-26-000003), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

26-02-2026

TG Therapeutics, Inc. filed a Form 8-K on 2026-02-26 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were disclosed in the filing description. This is an informational earnings-related disclosure without quantified performance metrics.

26-02-2026

BlackSky Technology Inc. filed an 8-K on February 26, 2026 (AccNo: 0001753539-26-000009), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics were disclosed in the provided filing information. This is a multi-item mandatory filing typical for earnings releases, but lacks detailed financial data for impact assessment.

26-02-2026

Hilton Grand Vacations Inc. filed an 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. All quantitative financial metrics are NOT_DISCLOSED.

26-02-2026

Tecnoglass Inc. filed an 8-K on February 26, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. No positive, negative, or flat performance indicators are mentioned.

26-02-2026

Vital Farms, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reason for change, and any financial metrics are NOT_DISCLOSED. No quantitative data, named executives, or scheduled events are provided in the available information.

26-02-2026

Phathom Pharmaceuticals, Inc. filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the filing summary. This is a standard voluntary disclosure for financial results, likely related to quarterly or annual earnings.

26-02-2026

FRACTYL HEALTH, INC. filed a Form 8-K on 2026-02-26 reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing disclosing material non-public information with attached exhibits. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events are detailed in the filing summary.

26-02-2026

Akebia Therapeutics, Inc. filed an 8-K on 2026-02-26 under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other quantitative data are disclosed in the provided filing information. Sector details are not specified.

26-02-2026

Zai Lab Ltd filed an 8-K on February 26, 2026 (AccNo: 0001704292-26-000014), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no directional performance indicators available.

26-02-2026

Immunic, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001193805-26-000181), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were mentioned in the provided filing information.

26-02-2026

Bentley Systems Inc filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or quantitative details are provided in the filing summary. This appears to be a standard earnings-related disclosure without disclosed positives, negatives, or flat performance indicators.

26-02-2026

Avanos Medical, Inc. filed an 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or comparisons were disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative data available.

26-02-2026

Shift4 Payments, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a standard voluntary earnings-related disclosure with no specific revenue, earnings, guidance, or other quantitative metrics detailed in the filing summary. No period-over-period comparisons, positive or negative changes, or operational details are provided.

26-02-2026

GigaCloud Technology Inc filed a Form 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This is a standard disclosure for financial results, likely related to quarterly or annual earnings. No specific revenue, earnings, guidance, or period-over-period metrics are detailed in the provided filing summary.

26-02-2026

Niagen Bioscience, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001386570-26-000003, Size: 162 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, financial impacts, or exhibits provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

26-02-2026

NovoCure Ltd filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing description. This is a standard voluntary disclosure of financial results with attached exhibits.

26-02-2026

Shake Shack Inc. filed a Form 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period metrics are disclosed in the provided filing details. This multi-item voluntary disclosure provides an informational update on operations without quantitative data for impact assessment.

26-02-2026

Carlyle Group Inc. filed an 8-K on February 26, 2026 (AccNo: 0001527166-26-000006, Size: 3 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item, voluntary disclosure as Item 7.01 is not mandatory. No specific content details, financial metrics, transactions, or material events are disclosed in the provided filing summary.

26-02-2026

Butterfly Network, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.

26-02-2026

Hagerty, Inc. filed a Form 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, Item 7.01 for Regulation FD disclosure, and Item 9.01 for financial statements and exhibits. This is a multi-item filing announcing financial results, but specific revenue, earnings, or other quantitative metrics are NOT_DISCLOSED. No period-over-period comparisons, guidance, or balance sheet effects are provided in the filing description.

26-02-2026

Shenandoah Telecommunications Co/VA/ filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or period-over-period comparisons were disclosed in the filing summary. This is a standard earnings-related disclosure with all quantitative financial metrics NOT_DISCLOSED.

26-02-2026

Kairos Pharma, LTD. filed a Form 8-K on February 26, 2026 (AccNo: 0001493152-26-008116), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing summary. This appears to be a multi-item, likely voluntary disclosure with no quantified financial or operational impacts mentioned.

26-02-2026

Viridian Therapeutics, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period changes, or guidance were disclosed in the provided filing information. This appears to be an earnings-related disclosure, but detailed financial data is NOT_DISCLOSED.

26-02-2026

Teleflex Inc filed a Form 8-K on February 26, 2026, reporting results of operations and financial condition (Item 2.02), costs associated with exit or disposal activities (Item 2.05), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This multi-item filing indicates quarterly financial results alongside restructuring or disposal-related costs, suggesting potential mixed performance with operational updates but added expenses. Specific revenue, earnings, cost amounts, guidance, or period-over-period changes are NOT_DISCLOSED.

26-02-2026

Papa Johns International Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001628280-26-011964), furnishing information under Item 2.02 regarding results of operations and financial condition, and under Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This is a standard earnings-related disclosure with no quantitative metrics available.

26-02-2026

ADTRAN Holdings, Inc. filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, or other quantitative metrics were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without extracted numerical data.

26-02-2026

Vistra Corp. filed a Form 8-K on 2026-02-26 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure typical for earnings releases.

26-02-2026

PENN Entertainment, Inc. filed an 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This represents a standard voluntary disclosure of quarterly or periodic financial results.

26-02-2026

Anika Therapeutics, Inc. filed an 8-K on February 26, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer or director change under Item 5.02, with exhibits under Item 9.01. Specific details on the leadership change, including position affected, appointment or resignation status, reasons, and timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or named individuals are provided in the available information.

26-02-2026

Aclaris Therapeutics, Inc. filed an 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This represents a standard voluntary disclosure of financial results typically tied to an earnings release.

26-02-2026

Kymera Therapeutics, Inc. filed a Form 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative metrics available.

26-02-2026

Eagle Point Income Co Inc. filed an 8-K on February 26, 2026, reporting solely under Item 8.01 Other Events. No details on the core event, financial impacts, transactions, metrics, or scheduled events are disclosed in the provided filing information. This is a voluntary disclosure with no quantitative data or directional implications mentioned.

26-02-2026

Nuveen Churchill Direct Lending Corp. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance numbers available.

26-02-2026

Lindblad Expeditions Holdings, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001437749-26-005736), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing disclosing the company's financial results, likely including a press release and tables as exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics were explicitly stated in the provided filing details.

26-02-2026

C4 Therapeutics, Inc. filed a Form 8-K on February 26, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed financial data available.

26-02-2026

Lantheus Holdings, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-073439), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were explicitly stated in the filing information provided.

26-02-2026

Wave Life Sciences Ltd. filed an 8-K on 2026-02-26 furnishing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, or period-over-period comparisons were disclosed in the provided filing information. Sector not specified.

26-02-2026

Installed Building Products, Inc. filed an 8-K on 2026-02-26 reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information.

26-02-2026

Cheniere Energy Partners, L.P. filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are detailed in the provided filing metadata. This appears to be a standard earnings-related disclosure without quantified metrics available.

26-02-2026

E.W. SCRIPPS Co filed an 8-K on February 26, 2026 (AccNo: 0000832428-26-000006), disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change including key position affected, appointment or resignation status, reason, or timing are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are disclosed.

26-02-2026

Cognizant Technology Solutions Corp filed an 8-K on 2026-02-26 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or impacts are provided in the available information. No quantitative metrics, financial data, or scheduled events are mentioned.

26-02-2026

Vera Therapeutics, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-073421, Size: 696 KB), reporting under Item 2.02 Results of Operations and Financial Condition, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing details. This is a multi-item, mandatory disclosure typical for earnings releases, but lacks detailed data for impact assessment.

26-02-2026

Thryv Holdings, Inc. filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided information. This is a multi-item voluntary filing typical for earnings announcements.

26-02-2026

Payoneer Global Inc. filed an 8-K on 2026-02-26 under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional financial data available.

26-02-2026

Crescent Biopharma, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001628280-26-011988, Size: 319 KB), disclosing results of operations and financial condition under Item 2.02 along with financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were provided in the filing summary. This represents a standard voluntary earnings-related disclosure with no directional financial metrics disclosed.

26-02-2026

Bread Financial Holdings, Inc. filed an 8-K on February 26, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the filing summary provided. Critical details such as core events, dollar values, or performance metrics are NOT_DISCLOSED.

26-02-2026

Rhythm Pharmaceuticals, Inc. filed an 8-K on 2026-02-26 reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing focused on financial results disclosure.

26-02-2026

Gibraltar Industries, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details, scheduled events, or strategic updates were mentioned.

26-02-2026

ACM Research, Inc. filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

• ·Accession Number: 0001628280-26-011998
• ·Filing size: 613 KB
• ·Sector: NOT_DISCLOSED

26-02-2026

Intellia Therapeutics, Inc. filed an 8-K on February 26, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information. This is a standard disclosure for financial results with no detailed quantitative data available.

26-02-2026

PROCEPT BioRobotics Corp filed an 8-K on February 26, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific events, transactions, financial metrics, positive or negative changes, or other details are explicitly stated in the provided filing information. All quantitative data and impacts are NOT_DISCLOSED.

26-02-2026

Perimeter Solutions, Inc. filed a Form 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard earnings-related disclosure. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are explicitly stated in the provided filing information.

26-02-2026

Matador Resources Co filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the attached exhibits are disclosed in the provided filing summary. No financial metrics, transactions, or directional impacts are mentioned.

26-02-2026

USA TODAY Co., Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001579684-26-000008), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This multi-item filing represents a standard voluntary earnings release with no specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons provided in the excerpt. Critical quantitative data and operational details remain NOT_DISCLOSED.

26-02-2026

Victory Capital Holdings, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This is an informational filing with no quantified positive or negative impacts mentioned.

26-02-2026

ACI Worldwide, Inc. filed an 8-K on February 26, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer involved, nature of the change, financial metrics, or any quantitative data are disclosed in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

26-02-2026

Viatris Inc filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 2.05 (Costs Associated with Exit or Disposal Activities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). The filing discloses financial results alongside costs related to exit or disposal activities, suggesting potential restructuring, but no specific metrics, amounts, or performance details are provided. This is a multi-item mandatory disclosure with no quantified positive or negative impacts visible.

26-02-2026

vTv Therapeutics Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001641489-26-000005, Size: 4 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the disclosed information, events, financial metrics, or exhibits provided. No positive or negative metrics are mentioned.

26-02-2026

Heron Therapeutics, Inc. filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative data were detailed in the filing summary provided.

26-02-2026

Gray Media, Inc. filed an 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or the nature of the financial statements/exhibits are disclosed in the provided filing information. This is an informational filing with no quantitative metrics, positive or negative performance indicators, or directional implications provided.

26-02-2026

Aquestive Therapeutics, Inc. filed a Form 8-K on February 26, 2026, under Item 7.01 for Regulation FD Disclosure, indicating a voluntary release of potentially material non-public information, with exhibits attached under Item 9.01. No quantitative financial metrics, transaction details, period-over-period comparisons, or specific events are disclosed in the filing metadata. This is a multi-item informational filing with no directional financial impact evident.

26-02-2026

Delcath Systems, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition as part of its financial results announcement. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were mentioned in the provided filing information. All quantitative metrics and further details are NOT_DISCLOSED.

26-02-2026

Picard Medical, Inc. filed a Form 8-K on February 26, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing summary. The disclosure appears informational with no quantified positive or negative impacts explicitly stated.

• ·Accession Number: 0001829126-26-001652
• ·File Size: 205 KB

26-02-2026

MannKind Corp filed an 8-K on February 26, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 attaching Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are detailed in the provided filing information. This represents a standard mandatory disclosure for financial results without quantified metrics available.

26-02-2026

Novavax Inc filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, balance sheet details, or period-over-period comparisons are disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantifiable positive or negative indicators available.

26-02-2026

Golden Matrix Group, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001477932-26-001050, Size: 185 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on events, transactions, financial metrics, or quantitative data disclosed in the provided summary. No positive, negative, or flat performance metrics are mentioned.

26-02-2026

Vericel Corp filed an 8-K on February 26, 2026 (AccNo: 0001628280-26-012003, Size: 378 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard mandatory disclosure for financial results without detailed outcomes available.

• ·AccNo: 0001628280-26-012003
• ·File Size: 378 KB
• ·Sector: not specified
• ·Event Type: Financial Results

26-02-2026

Rackspace Technology, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This is a multi-item mandatory filing for financial results announcement. No specific financial metrics, period-over-period changes, guidance, or quantitative data are disclosed in the provided filing information.

26-02-2026

MVB Financial Corp filed an 8-K on 2026-02-26 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific details on the agreement, obligation size, terms, or financial impacts are disclosed in the provided information. This represents a multi-item mandatory disclosure with potential balance sheet implications, but lacks quantification.

26-02-2026

CACI International Inc. filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing summary. This appears to be a multi-item informational filing with no quantified metrics or directional impacts mentioned.

26-02-2026

Disc Medicine, Inc. filed an 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This constitutes a standard earnings-related disclosure without quantified metrics.

26-02-2026

Edgewise Therapeutics, Inc. filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are mentioned in the filing description. This appears to be a standard voluntary quarterly financial results disclosure.

26-02-2026

Burford Capital Ltd filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific metrics, transaction details, or performance data are NOT_DISCLOSED. No positive or negative financial changes, guidance, or comparisons are provided in the available information.

26-02-2026

Universal Health Services Inc filed an 8-K on 2026-02-26 disclosing Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information. No positive or negative performance details, period-over-period comparisons, or material events with dollar values are mentioned.

26-02-2026

Hertz Global Holdings, Inc. filed an 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative financial data are explicitly stated in the provided filing details. This appears to be a standard earnings-related disclosure without detailed metrics available.

26-02-2026

Roadzen Inc. filed an 8-K on 2026-02-26 reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, transaction terms, parties, financial impacts, or metrics are disclosed. This is a multi-item mandatory disclosure with no quantitative data provided.

• ·Filing Accession Number: 0001493152-26-008128
• ·Filing Size: 319 KB

26-02-2026

Arrow Financial Corp filed a Form 8-K on February 26, 2026 (AccNo: 0000717538-26-000030, Size: 48 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative metrics, transaction details, financial impacts, or period-over-period comparisons are disclosed. The large filing size suggests substantial exhibits, likely including the agreement text.

26-02-2026

Playtika Holding Corp. filed an 8-K on February 26, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative data available.

26-02-2026

Freshworks Inc. filed an 8-K on February 26, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or exhibits are disclosed in the filing summary provided. This appears to be a multi-item voluntary disclosure with no quantitative financial metrics or directional impacts mentioned.

26-02-2026

Sunoco LP filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-073531), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely disclosing financial results, but no specific revenue, earnings, or other quantitative metrics are mentioned. No positive or negative performance indicators, comparisons, or guidance changes are provided in the filing details.

26-02-2026

CRA International, Inc. filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or guidance details are provided in the filing summary. This appears to be a standard earnings-related disclosure without quantified data available.

26-02-2026

Marcus Corp filed an 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the filing details provided. This appears to be a standard earnings-related disclosure without detailed performance data available.

26-02-2026

SIRIUS XM HOLDINGS INC. filed a Form 8-K on 2026-02-26 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the filing summary. This is a multi-item informational filing with no quantified financial metrics, positive or negative developments, or performance comparisons provided.

26-02-2026

Runway Growth Finance Corp. filed a Form 8-K on February 26, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, financial metrics, numerical values, or period-over-period comparisons disclosed in the provided filing summary. Critical event details and exhibits are NOT_DISCLOSED.

26-02-2026

U S PHYSICAL THERAPY INC /NV filed an 8-K on February 26, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details on the officer, position, reason for change, or any impacts are NOT_DISCLOSED.

• ·Filing Accession Number: 0001140361-26-006882
• ·File size: 1 MB
• ·Sector: NOT_DISCLOSED

26-02-2026

Loar Holdings Inc. filed a Form 8-K on 2026-02-26 disclosing Item 2.02 Results of Operations and Financial Condition. No specific financial metrics, period-over-period comparisons, or quantitative data such as revenue, earnings, or guidance are explicitly stated in the provided filing information. No positive, negative, or flat performance indicators are mentioned.

26-02-2026

Bank of New York Mellon Corp filed an 8-K on February 26, 2026, reporting solely under Item 8.01 Other Events. No details on the specific event, financial impacts, transactions, or metrics are disclosed in the provided filing information. No positive or negative metrics are mentioned.

26-02-2026

Kindly MD, Inc. filed an 8-K on February 26, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers unregistered sales of equity securities (Item 3.02), departure or election of directors/officers and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific transaction details, financial metrics, parties, or values are disclosed.

26-02-2026

MSA Safety Inc filed an 8-K on February 26, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other event, financial metrics, transaction values, or impacts are disclosed in the filing summary. This appears to be a multi-item informational filing with attached exhibits.

26-02-2026

Manhattan Associates Inc filed an 8-K on February 26, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

26-02-2026

EQUITY LIFESTYLE PROPERTIES INC filed an 8-K on February 26, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing Regulation FD disclosure with attached exhibits, but no specific details on events, transactions, financial metrics, positive or negative changes, or performance comparisons are disclosed in the provided filing summary. No quantitative data or directional impacts are available.

26-02-2026

Koppers Holdings Inc. filed an 8-K on February 26, 2026 (AccNo: 0001315257-26-000010), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

26-02-2026

AMERICAN WOODMARK CORP filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or quantitative financial metrics were mentioned in the filing summary. This appears to be a standard earnings-related disclosure with no detailed performance data provided.

26-02-2026

Redwire Corp filed a multi-item 8-K on February 26, 2026, reporting entry into a new material definitive agreement (Item 1.01), termination of a prior material definitive agreement (Item 1.02), results of operations and financial condition (Item 2.02), and creation of a new direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits under Item 9.01. No specific details on the agreements, transaction values, financial metrics, or impacts are disclosed. This combination suggests both new commitments and terminations, but lacks quantification for balanced assessment.

26-02-2026

USA Rare Earth, Inc. filed an 8-K on February 26, 2026, under Item 7.01 Regulation FD Disclosure. No specific core event, transaction details, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing information.

26-02-2026

Nuwellis, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned in the provided filing information.

26-02-2026

Fate Therapeutics Inc filed an 8-K on February 26, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or detailed operational results are provided in the filing summary. This constitutes a standard earnings-related disclosure without quantified impacts.

26-02-2026

Cartesian Growth Corp III filed an 8-K on February 26, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, financial statements, or exhibits are provided in the filing summary. No quantitative metrics, transactions, positive or negative changes, or material impacts are disclosed.

26-02-2026

Kilroy Realty Corp filed an 8-K on February 26, 2026 (AccNo: 0001628280-26-012017), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any governance implications are NOT_DISCLOSED. No quantitative data, financial metrics, scheduled events, or further context on board outcomes or succession planning is provided in the available information.

26-02-2026

Hudson Pacific Properties, Inc. filed an 8-K on 2026-02-26 reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are NOT_DISCLOSED in the provided information.

26-02-2026

JFrog Ltd filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details regarding the nature of the other events or the contents of any financial statements and exhibits are NOT_DISCLOSED. No quantitative metrics, transactions, or directional impacts are mentioned in the filing summary.

26-02-2026

Pathward Financial, Inc. filed an 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the events, transactions, financial metrics, or exhibits provided in the disclosure summary. No quantitative impacts, positive or negative metrics, or strategic implications are disclosed.

26-02-2026

PUBLIC SERVICE ENTERPRISE GROUP INC filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period changes, guidance, or other quantitative details are disclosed in the provided filing information. This is a multi-item filing focused on financial results disclosure.

26-02-2026

TriMas Corp filed an 8-K on February 26, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing details. This is an informational disclosure of financial results without quantified metrics.

26-02-2026

LSB Industries, Inc. filed a Form 8-K on February 26, 2026, under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, guidance, or other quantitative details are mentioned in the filing information provided. Sector is not specified.

26-02-2026

Biofrontera Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001493152-26-008136, Size: 276 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the nature of the other events or the attached exhibits. No financial metrics, transactions, or directional information are disclosed.

26-02-2026

Millrose Properties, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This is a multi-item filing focused on financial results.

26-02-2026

EMCOR Group, Inc. filed an 8-K on February 26, 2026, disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, comparisons, or other financial metrics are detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified performance data.

26-02-2026

MSC Income Fund, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001535778-26-000020), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the events, transactions, financial metrics, or exhibits provided in the summary. No quantitative data, period-over-period comparisons, or directional impacts are disclosed.

26-02-2026

STANDARD MOTOR PRODUCTS, INC. filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed quantitative data available.

26-02-2026

WEC Energy Group, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events or the nature of the attached financial statements and exhibits are disclosed in the provided filing summary.

• ·Multi-item 8-K filing (Items 8.01 and 9.01)
• ·Filing Accession Number: 0001104659-26-020174
• ·File size: 430 KB
• ·Critical missing information: Content details of Item 8.01 events and Item 9.01 exhibits

26-02-2026

Essential Utilities, Inc. filed a Form 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance changes, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

26-02-2026

ACME UNITED CORP filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details such as revenue, earnings, or balance sheet impacts are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

26-02-2026

Verisk Analytics, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with Accession Number 0001193125-26-074420 and a file size of 617 KB. No specific details on the events, transactions, financial metrics, or exhibits are disclosed.

26-02-2026

Sempra filed an 8-K on 2026-02-26 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. The filing size is 2 MB with AccNo 0001032208-26-000008.

• ·AccNo: 0001032208-26-000008

26-02-2026

URBAN OUTFITTERS INC filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-074606, size 1 MB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative data, positive or negative metrics, or directional implications mentioned.

26-02-2026

Avalon GloboCare Corp. filed an 8-K on February 26, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, positive or negative changes, or other details are disclosed in the provided filing information.

26-02-2026

Entergy Louisiana, LLC filed an 8-K on February 26, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantitative data provided.

26-02-2026

Soren Acquisition Corp. filed an 8-K on February 26, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) disclosing a Merger/Acquisition event. No specific details on deal structure, parties, valuation, financial terms, synergies, or impacts are provided in the filing summary. No quantitative metrics, comparisons, positive or negative changes, or scheduled events mentioned.

26-02-2026

Zoomcar Holdings, Inc. filed a multi-item Form 8-K on 2026-02-26 disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), accompanied by Regulation FD disclosure (Item 7.01). While Item 1.01 signals a potentially strategic transaction, Item 3.02 raises dilution concerns from equity issuances. No transaction values, financial impacts, or specific details are disclosed.

26-02-2026

Alignment Healthcare, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001171843-26-001139), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative financial metrics are mentioned in the provided filing details. Sector is not specified.

26-02-2026

Organogenesis Holdings Inc. filed a Form 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), disclosing financial results. This multi-item filing appears timely based on the filing date matching the event date. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were explicitly stated in the provided filing information.

26-02-2026

TABLE TRAC INC filed an 8-K on February 26, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed. No financial metrics, transactions, or performance data are provided.

26-02-2026

International Bancshares Corp filed an 8-K on February 26, 2026 (AccNo: 0001104659-26-020307, Size: 170 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing summary. This is an informational earnings-related disclosure with no quantitative details available.

26-02-2026

Innventure, Inc. filed a Form 8-K on February 26, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosed information, financial metrics, transactions, or exhibits were provided in the filing summary. This appears to be a voluntary informational filing without quantified positive or negative impacts.

26-02-2026

POPULAR, INC. filed an 8-K on February 26, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified financial metrics, positive or negative developments, or directional implications mentioned.

26-02-2026

Helios Technologies, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative metrics are provided in the filing summary. This appears to be a routine disclosure without additional context on governance or market implications.

26-02-2026

Ashford Hospitality Trust Inc filed a Form 8-K on February 26, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing information. The disclosure appears informational with exhibits attached, but content details are NOT_DISCLOSED.

26-02-2026

TIGO ENERGY, INC. filed an 8-K on 2026-02-26 reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. Specific details of the material definitive agreement, other events, transaction size, financial impacts, or any quantitative metrics are NOT_DISCLOSED in the provided filing summary. No positive or negative performance metrics, comparisons, or guidance changes are mentioned.

26-02-2026

DXP Enterprises Inc filed an 8-K on February 26, 2026, under Item 2.02 announcing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard financial results disclosure with no quantitative details available.

26-02-2026

LEE ENTERPRISES, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0000058361-26-000017), reporting Item 5.08 regarding Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 and Item 8.01 for Other Events. No quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the nominations or events are disclosed. This is a multi-item governance-related filing with no mentioned positive or negative financial impacts.

26-02-2026

FS Bancorp, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. No quantitative metrics, comparisons, or directional impacts are provided.

26-02-2026

Elevance Health, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 7.01 (Regulation FD Disclosure). No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other numerical data mentioned.

26-02-2026

CHASE PACKAGING CORP filed an 8-K on 2026-02-26 disclosing Item 3.03 Material Modifications to Rights of Security Holders and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the modifications provided in the available information. No positive or negative performance metrics are mentioned.

26-02-2026

UNION BANKSHARES INC filed an 8-K on 2026-02-26 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative data are disclosed in the provided filing information.

26-02-2026

Edison International filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No financial metrics, transactions, or performance data are mentioned.

26-02-2026

EVERTEC, Inc. filed a Form 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. This multi-item filing includes voluntary disclosure of earnings-related information with attached exhibits. No specific revenue, earnings, or other quantitative financial metrics are disclosed in the provided filing details.

26-02-2026

Airgain Inc filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076559), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, comparisons, or other metrics are disclosed in the provided details. No positive or negative performance indicators, guidance, or balance sheet effects are mentioned.

26-02-2026

Nerdy Inc. filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076562), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

26-02-2026

PRA Group Inc filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item filing typical for earnings disclosures. No specific revenue, earnings, guidance, comparisons, or other metrics are disclosed in the provided information.

26-02-2026

AvePoint, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. AccNo: 0001171843-26-001140; File size: 379 KB.

• ·Sector: not specified
• ·Source: us_sec
• ·Event Type: Financial Results

26-02-2026

Block, Inc. filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02 and costs associated with exit or disposal activities under Item 2.05. Item 9.01 includes financial statements and exhibits. No specific financial metrics, period-over-period changes, or quantified impacts are disclosed.

26-02-2026

Bicara Therapeutics Inc. filed a Form 8-K on 2026-02-26 reporting entry into a material definitive agreement under Item 1.01 and results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, financial metrics, or performance comparisons provided in the available information. No positive or negative metrics are disclosed.

26-02-2026

Applied Optoelectronics, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no detailed performance data available.

26-02-2026

Insight Molecular Diagnostics Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001493152-26-008169), disclosing entry into a material definitive agreement under Item 1.01 and providing financial statements and exhibits under Item 9.01. No details on the agreement's parties, terms, value, strategic importance, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

• ·Filing size: 202 KB
• ·Accession Number: 0001493152-26-008169
• ·Sector: NOT_DISCLOSED

26-02-2026

Natera, Inc. filed an 8-K on 2026-02-26 under Item 2.02 announcing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without quantified metrics available.

26-02-2026

Align Technology Inc filed an 8-K on February 26, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 references financial statements and exhibits. No financial metrics, transaction values, or specific details on the amendments provided.

26-02-2026

FIDUS INVESTMENT Corp filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or guidance are disclosed in the provided filing information. This appears to be an informational disclosure of financial results without detailed quantitative data.

26-02-2026

Figure Technology Solutions, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or quantitative details on revenue, earnings, balance sheet effects, or guidance were disclosed in the provided filing information.

26-02-2026

Agree Realty Corp filed an 8-K on February 26, 2026 (AccNo: 0000917251-26-000017, size: 10 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or operational details are disclosed in the provided filing information. This appears to be a voluntary disclosure likely including exhibits such as a press release or presentation.

26-02-2026

Teledyne Technologies Inc filed an 8-K on 2026-02-26 under Items 1.01 and 9.01, disclosing entry into a material definitive agreement with financial statements and exhibits attached. No details on the agreement's nature, parties, value, strategic rationale, or financial impacts are provided in the filing summary. No quantitative metrics, period-over-period changes, or scheduled events are mentioned.

26-02-2026

Targa Resources Corp. filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076556), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure without detailed content available.

26-02-2026

CoreWeave, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001769628-26-000094), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. Sector details are NOT_DISCLOSED.

• ·Multi-item 8-K filing (Items 2.02 and 9.01)
• ·Event type: Financial Results
• ·Source: US SEC, Size: 545 KB

26-02-2026

Sweetgreen, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001628280-26-012331), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings announcements, but no specific revenue, earnings, guidance, balance sheet details, or other quantitative metrics are disclosed in the provided filing information. File size is 523 KB.

26-02-2026

NetApp, Inc. filed an 8-K on 2026-02-26 under Item 2.02 disclosing Results of Operations and Financial Condition and under Item 9.01 including Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or quantitative details are mentioned in the filing information provided. This is an informational earnings-related disclosure with no directional performance data available.

26-02-2026

Personalis, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet effects, guidance, or other financial metrics are disclosed in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

26-02-2026

NPK International Inc. filed an 8-K on February 26, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, or quantitative data are disclosed in the filing summary. Critical details such as event descriptions, numbers, or impacts are not provided.

26-02-2026

TFS Financial CORP filed a Form 8-K on 2026-02-26 under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transaction values, metrics, or scheduled events are disclosed in the provided filing information. This is a single-item voluntary disclosure with no quantitative data available.

26-02-2026

Progyny, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). No specific financial metrics, period-over-period changes, or quantitative data are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.

26-02-2026

ARCH Capital Group Ltd. filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the filing summary provided. No quantitative metrics, transactions, or directional performance indicators (positive, negative, or flat) are mentioned.

26-02-2026

Expensify, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. This appears to be a multi-item filing related to financial results announcement.

26-02-2026

Xenon Pharmaceuticals Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-076530), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for financial results announcements, but no specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period changes, or balance sheet details are available.

26-02-2026

Parsons Corp filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076537), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any quantitative impacts are provided. Sector information is not specified.

26-02-2026

PACS Group, Inc. filed an 8-K on February 26, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

26-02-2026

MP Materials Corp. filed an 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure without detailed financial data available.

26-02-2026

Duolingo, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001628280-26-012246), reporting results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for quarterly or annual financial results announcements. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.

26-02-2026

Pacira BioSciences, Inc. filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified positives, negatives, or flat performance indicators.

26-02-2026

Neurogene Inc. filed an 8-K on February 26, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific financial metrics, transactions, or operational details disclosed in the provided filing information. Critical content of the disclosure is NOT_DISCLOSED.

26-02-2026

PLUG POWER INC filed an 8-K on 2026-02-26 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are disclosed in the provided filing summary. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

26-02-2026

OneSpan Inc. filed an 8-K on February 26, 2026, specifically under Item 9.01 Financial Statements and Exhibits, with a file size of 584 KB and Accession Number 0001044777-26-000006. No specific financial statements, exhibits, transactions, metrics, or events are detailed in the provided filing information. This appears to be an informational filing without disclosed material events or quantitative data.

26-02-2026

Syndax Pharmaceuticals Inc filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076522), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with exhibits likely containing detailed financials.

26-02-2026

Intuit Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0000896878-26-000012, Size: 629 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results but provides no specific metrics, comparisons, or details on performance. No positive, negative, or flat metrics are disclosed.

26-02-2026

Liquidity Services Inc filed an 8-K on February 26, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote outcomes, proposals, or any quantitative results such as shares voted, for/against, abstentions, or broker non-votes are disclosed. This is a standard informational disclosure with no financial metrics, positive or negative changes, or strategic implications mentioned.

26-02-2026

Energy Fuels Inc filed a Form 8-K on February 26, 2026 (AccNo: 0001062993-26-001182, size 13 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of potentially material information via attached exhibits, but no specific events, transactions, metrics, positives, negatives, or flat performance are detailed. No quantitative financial data or comparisons provided.

26-02-2026

Keros Therapeutics, Inc. filed an 8-K on February 26, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons for change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·Filing accession number: 0001664710-26-000008
• ·File size: 232 KB
• ·Sector: NOT_DISCLOSED

26-02-2026

DHI Group, Inc. filed a Form 8-K on February 26, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits, likely related to the accountant change. No quantitative metrics, reasons for the change, prior/new firm details, or period-over-period comparisons are mentioned.

26-02-2026

Biodesix Inc filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076521), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative financial data were disclosed in the provided filing details. This is a standard voluntary disclosure of financial results with no directional performance indicators available.

• ·Filing size: 559 KB
• ·Sector: NOT_DISCLOSED

26-02-2026

Cable One, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard voluntary disclosure of financial results with attached exhibits.

26-02-2026

Willdan Group, Inc. filed an 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are disclosed in the provided filing details. This is an informational earnings-related disclosure without directional performance indicators.

26-02-2026

DENTSPLY SIRONA Inc. filed a Form 8-K on 2026-02-26 reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue figures, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard disclosure for financial results without quantified details.

26-02-2026

Brink's Co filed a Form 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement's nature, parties, terms, or financial impacts disclosed in the provided information. No quantitative metrics, period-over-period comparisons, or directional performance indicators (positive, negative, or flat) are mentioned.

26-02-2026

Helio Corp filed a Form 8-K on February 26, 2026, reporting changes in its certifying accountant under Item 4.01, a Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This multi-item filing highlights a potentially material event with the auditor change, which could signal concerns, while the Reg FD disclosure may contain additional information but lacks specifics here. No quantitative metrics, dollar values, or detailed reasons are disclosed.

26-02-2026

Asure Software Inc filed an 8-K on February 26, 2026 (AccNo: 0001628280-26-012293), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings announcements, but no specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided information. No positive or negative metrics are available, resulting in no directional insights.

26-02-2026

Strategic Storage Trust VI, Inc. filed an 8-K on February 26, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or directional information are disclosed in the filing summary.

26-02-2026

NATIONAL HEALTH INVESTORS INC filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or guidance details were provided in the filing summary. This represents a standard voluntary earnings-related disclosure without quantified financial impacts.

26-02-2026

Seer, Inc. filed a multi-item Form 8-K on February 26, 2026, reporting entry into a material definitive agreement under Item 1.01, material modifications to rights of security holders under Item 3.03, amendments to articles of incorporation or bylaws under Item 5.03, and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. No specific details on the agreement, modifications, amendments, financial impacts, or quantitative metrics are disclosed in the provided filing summary.

26-02-2026

FIGS, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing details.

26-02-2026

OrthoPediatrics Corp filed an 8-K on February 26, 2026 (AccNo: 0001425450-26-000009), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This appears to be a standard voluntary disclosure of financial results without detailed performance data available.

26-02-2026

Xponential Fitness, Inc. filed an 8-K on February 26, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without extracted performance data.

26-02-2026

Structure Therapeutics Inc. filed an 8-K on February 26, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are mentioned in the provided filing details. This is a standard voluntary disclosure of financial results with exhibits attached.

26-02-2026

NCR Atleos Corp filed an 8-K on 2026-02-26 disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits related to financial results. No specific revenue, earnings, balance sheet details, guidance, or performance metrics are disclosed in the provided filing information.

• ·Filing date: 2026-02-26
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

26-02-2026

MetLife Inc filed a Form 8-K on February 26, 2026, under Item 2.03 disclosing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. The filing also reports Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

26-02-2026

Elastic N.V. filed an 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This is a standard earnings-related disclosure. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are detailed in the provided filing information.

26-02-2026

National CineMedia, Inc. filed a Form 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, comparisons, or guidance are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data.

26-02-2026

OneStream, Inc. filed an 8-K on 2026-02-26 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition) with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics were mentioned in the provided filing details. Sector information was not specified.

26-02-2026

PAR Technology Corp filed a multi-item Form 8-K on February 26, 2026 (AccNo: 0000708821-26-000024), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period changes, guidance, or other quantitative details such as revenue, earnings, or balance sheet impacts are disclosed in the provided filing information. This filing pertains to financial results but lacks details to assess positive, negative, or flat performance across metrics.

26-02-2026

TPG Inc. filed a Form 8-K on February 26, 2026, reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing triggered by significant corporate developments, but no specific transaction details, dollar values, financial metrics, or quantitative impacts are disclosed. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

26-02-2026

NLIGHT, INC. filed an 8-K on February 26, 2026, disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a voluntary earnings-related disclosure with attached exhibits.

• ·AccNo: 0001124796-26-000010
• ·File size: 466 KB
• ·Sector: not specified

26-02-2026

Unity Bancorp Inc./NJ/ filed a Form 8-K on February 26, 2026 (AccNo: 0000920427-26-000008, Size: 226 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. All quantitative metrics, transactions, and impacts are NOT_DISCLOSED.

26-02-2026

Relay Therapeutics, Inc. filed a Form 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics were mentioned in the filing description. This is a standard voluntary earnings-related disclosure with no directional performance indicators provided.

26-02-2026

Aeva Technologies, Inc. filed an 8-K on February 26, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative metrics were detailed in the provided filing information. This represents a standard voluntary earnings-related disclosure without directional performance indicators.

26-02-2026

Caris Life Sciences, Inc. filed an 8-K on February 26, 2026 (AccNo: 0002019410-26-000011), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are provided in the available information. No positive or negative performance indicators, comparisons, or guidance changes are mentioned.

26-02-2026

Compass, Inc. filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This multi-item filing provides disclosure on operations and financial condition but contains no specific revenue, earnings, or other metrics in the provided information. No positive or negative performance details, guidance, or comparisons are disclosed.

26-02-2026

Janux Therapeutics, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076627), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or quantitative data are provided in the filing details. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

26-02-2026

Coupang, Inc. filed a Form 8-K on February 26, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed results available.

26-02-2026

NextEra Energy Inc filed an 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, financial metrics, transactions, or impacts are disclosed in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

26-02-2026

Alpha Teknova, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-076592), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing focused on financial results, but no specific revenue, earnings, balance sheet details, period-over-period changes, guidance, or other quantitative metrics are mentioned in the provided filing information. No positive or negative performance indicators are available.

26-02-2026

Phillips Edison & Company, Inc. filed an 8-K on 2026-02-26 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, which are mandatory disclosures. Item 8.01 covers other events and Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics (positive, negative, or flat) are disclosed.

• ·Multi-item 8-K filing (Items 1.01, 2.03, 8.01, 9.01)
• ·Filed same day as event date (2026-02-26), indicating timely disclosure

26-02-2026

Mind Medicine (MindMed) Inc. filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076612), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are mentioned. This is a standard earnings-related disclosure in the healthcare/biotech sector implied by company name, but sector explicitly not specified.

26-02-2026

Rocket Lab Corp filed an 8-K on 2026-02-26 under Item 2.02 reporting Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without further elaboration.

• ·Multi-item 8-K filing (Items 2.02 and 9.01)
• ·Filing date: 2026-02-26
• ·AccNo: 0001819994-26-000012
• ·Size: 495 KB
• ·Critical missing information: Actual financial statements, revenue, earnings, EPS, margins, cash position, guidance, YoY/QoQ comparisons, scheduled events (e.g., earnings call), insider activity, and detailed operational metrics - analysis quality severely limited without these.

26-02-2026

Diamond Hill Investment Group Inc filed an 8-K on 2026-02-26 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard earnings-related disclosure with attached financial statements. No specific revenue, earnings, or other quantitative metrics are disclosed in the provided filing details.

26-02-2026

Dell Technologies Inc. filed an 8-K on February 26, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

26-02-2026

Definitive Healthcare Corp. filed a Form 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits (AccNo: 0001193125-26-076609, Size: 1 MB). No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

26-02-2026

Emergent BioSolutions Inc. filed an 8-K on 2026-02-26 disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results but provides no specific revenue, earnings, or other quantitative metrics. No positive or negative performance indicators, guidance, or period-over-period comparisons are detailed in the available information.

26-02-2026

FOX FACTORY HOLDING CORP filed a Form 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. This multi-item filing pertains to financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are explicitly stated or available in the provided filing description.

26-02-2026

Braemar Hotels & Resorts Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed.

26-02-2026

PureCycle Technologies, Inc. filed a multi-item Form 8-K on February 26, 2026, reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), material modifications to rights of security holders (Item 3.03), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, or quantitative impacts are disclosed in the provided filing summary. This appears to be a comprehensive disclosure covering operational, governance, and strategic updates.

26-02-2026

STARZ ENTERTAINMENT CORP /CN/ filed an 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are provided in the filing details. This is a multi-item mandatory disclosure typical for quarterly financial results announcements.

26-02-2026

Sunrun Inc. filed an 8-K on February 26, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

26-02-2026

Solventum Corp filed an 8-K on February 26, 2026 (AccNo: 0001964738-26-000005), disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without directional performance indicators.

26-02-2026

Castle Biosciences Inc filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases.

26-02-2026

Strategic Education, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the filing information provided. This represents a standard voluntary earnings-related disclosure without quantifiable performance metrics.

26-02-2026

ICF International, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative performance details, comparisons, or impacts are provided in the filing summary.

26-02-2026

OPKO Health, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-076575), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be a standard voluntary earnings-related disclosure.

26-02-2026

Talen Energy Corp filed an 8-K on February 26, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational disclosure of financial results without detailed performance data.

26-02-2026

Zscaler, Inc. filed a Form 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information.

• ·AccNo: 0001713683-26-000047
• ·Filing date: 2026-02-26

26-02-2026

Clover Health Investments, Corp. /DE filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are detailed in the provided filing information. This represents a standard mandatory disclosure for financial results without quantified impacts.

26-02-2026

Sprout Social, Inc. filed a Form 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item filing typical for quarterly earnings releases. Specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are NOT_DISCLOSED.

26-02-2026

DiamondRock Hospitality Co filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure without quantified performance metrics.

26-02-2026

PubMatic, Inc. filed a Form 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue figures, earnings, guidance, period-over-period changes, or other quantitative details are mentioned in the provided filing information. This is a standard earnings-related disclosure with no directional performance indicators available.

26-02-2026

Global Net Lease, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001104659-26-020505, size: 304 KB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, operational data, or other details are explicitly stated in the filing summary provided. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits.

26-02-2026

Denali Therapeutics Inc. filed an 8-K on February 26, 2026 (AccNo: 0001714899-26-000020), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item voluntary disclosure of financial results with no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons provided in the filing description. No positive or negative metrics are disclosed.

26-02-2026

Flutter Entertainment plc filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure with no detailed performance data available.

26-02-2026

BITMINE IMMERSION TECHNOLOGIES, INC. filed an 8-K on 2026-02-26 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the Regulation FD disclosure content, financial metrics, transactions, or exhibits are provided. All quantitative data, events, and impacts are NOT_DISCLOSED.

26-02-2026

Crinetics Pharmaceuticals, Inc. filed a Form 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard voluntary earnings-related disclosure with AccNo 0001658247-26-000011 and file size 295 KB. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing information.

• ·AccNo: 0001658247-26-000011
• ·File Size: 295 KB
• ·Sector: NOT_DISCLOSED

26-02-2026

DoubleVerify Holdings, Inc. filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, transaction values, or other quantitative metrics are disclosed. No positive or negative performance indicators, comparisons, or scheduled events are mentioned.

26-02-2026

TheRealReal, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is an informational release of financial results with exhibits attached.

26-02-2026

STIFEL FINANCIAL CORP filed an 8-K on February 26, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events are disclosed in the filing metadata provided.

26-02-2026

Dexcom Inc filed an 8-K on February 26, 2026 (AccNo: 0001093557-26-000031), disclosing under Item 5.02 a departure of directors or certain officers, election or appointment of directors or officers, and/or compensatory arrangements of certain officers. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons for changes, timing, or quantitative impacts are disclosed.

26-02-2026

ITRON, INC. filed a Form 8-K on 2026-02-26 reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure with no specific dollar values, share counts, terms, or financial metrics disclosed. Potential implications include strategic shifts, balance sheet changes, and equity dilution, but details are NOT_DISCLOSED.

26-02-2026

SITE Centers Corp. filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076738), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure for financial results. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information.

26-02-2026

Ginkgo Bioworks Holdings, Inc. filed an 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are mentioned in the provided filing information. Sector is not specified.

26-02-2026

Sidus Space Inc. filed a Form 8-K on 2026-02-26 reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No details on the agreement's nature, parties, dollar value, strategic importance, or financial impacts are provided.

26-02-2026

AFFILIATED MANAGERS GROUP, INC. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer, position affected, reasons, or any quantitative metrics are disclosed.

26-02-2026

Alta Equipment Group Inc. filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076903), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. Sector details are not specified.

26-02-2026

Advanced Biomed Inc. filed an 8-K on February 26, 2026, disclosing under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, financial impacts, or quantitative metrics regarding these changes or events are provided. This is a multi-item filing with no disclosed positive or negative performance metrics.

26-02-2026

Palmer Square Capital BDC Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are detailed in the provided information. No positive or negative performance indicators, comparisons, or guidance are explicitly stated.

26-02-2026

SOUNDHOUND AI, INC. filed an 8-K on February 26, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing excerpt. This is a standard earnings-related disclosure with no detailed performance data available.

26-02-2026

Mayville Engineering Company, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

26-02-2026

ETHZilla Corp filed a Form 8-K on February 26, 2026, reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or change in fiscal year, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of amendments, disclosures, events, or exhibits provided. No financial metrics, transaction values, or quantitative impacts are disclosed.

26-02-2026

Alerus Financial Corp filed an 8-K on February 26, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are provided in the filing summary. This appears to be an informational filing with no quantified metrics or directional impacts disclosed.

26-02-2026

Village Farms International, Inc. filed an 8-K on February 26, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or quantitative data are detailed in the provided filing information. This appears to be a multi-item informational filing with attached exhibits, likely a press release or presentation.

26-02-2026

MidCap Financial Investment Corp filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-076894, Size: 407 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative metrics were disclosed in the provided filing details. No positive, negative, or flat performance indicators were mentioned.

• ·Filing Accession Number: 0001193125-26-076894
• ·Filing Size: 407 KB

26-02-2026

Rexford Industrial Realty, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details such as the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

26-02-2026

Tectonic Therapeutic, Inc. filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, or quantitative data were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with no detailed performance indicators available.

26-02-2026

Averin Capital Acquisition Corp. filed an 8-K on 2026-02-26 under Item 8.01 (Other Events) announcing a merger/acquisition event and Item 9.01 (Financial Statements and Exhibits). No specific deal structure, parties involved, valuation, financial terms, strategic rationale, or quantitative metrics are disclosed in the filing summary. All key transaction details remain NOT_DISCLOSED.

26-02-2026

Amphastar Pharmaceuticals, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001297184-26-000007), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other financial metrics were provided in the filing details. This appears to be a standard earnings-related disclosure without quantified performance data.

26-02-2026

Smart Sand, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001529628-26-000007, Size: 526 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed.

26-02-2026

Revelation Biosciences, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-076833), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were disclosed in the provided filing information. The filing size is 443 KB, with sector not specified.

26-02-2026

Isabella Bank Corp filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantitative data or performance metrics mentioned.

26-02-2026

Oportun Financial Corp filed an 8-K on February 26, 2026, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or quantitative data such as revenue, earnings, or guidance are mentioned in the filing details provided. This represents a standard earnings-related disclosure without disclosed positives, negatives, or flat performance indicators.

26-02-2026

Monster Beverage Corp filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. This is a standard earnings-related multi-item filing with no details on positive or negative performance.

26-02-2026

Ambarella Inc filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02 and an officer change or election/appointment under Item 5.02, with exhibits under Item 9.01. Specific details on the affected officer position, whether it is an appointment or departure, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.

26-02-2026

Tutor Perini Corp filed an 8-K on February 26, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard earnings-related disclosure with no extracted positive or negative performance indicators.

26-02-2026

Cytek Biosciences, Inc. filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are available.

26-02-2026

MARA Holdings, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001507605-26-000004), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a voluntary disclosure of financial results. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information.

26-02-2026

Rocket Pharmaceuticals, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001140361-26-006981), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard financial results disclosure without quantified metrics available.

26-02-2026

MasTec Inc filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. This is a multi-item informational filing typical for quarterly or annual earnings releases.

26-02-2026

Assured Guaranty Ltd filed a Form 8-K on February 26, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are explicitly stated in the provided filing details. This appears to be a standard earnings-related disclosure without quantified metrics available.

26-02-2026

InPoint Commercial Real Estate Income, Inc. filed a Form 8-K on February 26, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the event, transaction values, financial metrics, or other quantitative data are disclosed in the provided filing metadata. This is a single-item filing with no mentioned positive or negative performance indicators.

26-02-2026

Arcosa, Inc. filed an 8-K on February 26, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition under Item 2.02, and financial statements/exhibits under Item 9.01. No specific details on the key position affected, individual involved, reason for change, appointment/resignation status, or financial metrics are explicitly stated or quantified in the provided filing information. Sector details are not specified.

26-02-2026

American Healthcare REIT, Inc. filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or quantitative details are provided in the filing metadata. This appears to be a standard earnings-related disclosure without extracted numerical data.

26-02-2026

SUI Group Holdings Ltd. filed an 8-K on February 26, 2026 (AccNo: 0001654954-26-001610), reporting under Item 2.02 Results of Operations and Financial Condition, with financial statements and exhibits attached under Item 9.01. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure without detailed quantitative data available.

• ·Sector: not specified
• ·Filing size: 174 KB

26-02-2026

Grindr Inc. filed a Form 8-K on 2026-02-26 reporting entry into a material definitive agreement under Item 1.01 and results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction size, financial metrics, or performance provided in the available information. No positive or negative metrics are disclosed.

26-02-2026

INNODATA INC filed an 8-K on 2026-02-26 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other financial metrics are mentioned in the filing details provided. No positive or negative performance indicators, transaction values, or operational changes are disclosed.

26-02-2026

Baldwin Insurance Group, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001781755-26-000015), disclosing Results of Operations and Financial Condition under Item 2.02 along with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. This is a standard financial results announcement with no quantitative metrics or directional performance indicators available.

26-02-2026

Quanex Building Products CORP filed an 8-K on February 26, 2026 (AccNo: 0001171843-26-001142, Size: 213 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or quantitative data are detailed in the filing summary provided. This appears to be a voluntary disclosure likely including attached exhibits such as a press release or presentation.

26-02-2026

Compass Diversified Holdings filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are mentioned in the provided filing summary. This is a standard voluntary earnings-related disclosure with no directional performance indicators available.

26-02-2026

Molina Healthcare, Inc. filed an 8-K on February 26, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. This appears to be a voluntary disclosure with no directional impact evident.

26-02-2026

Nelnet Inc filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without quantified performance data.

• ·AccNo: 0001258602-26-000013
• ·File size: 5 MB
• ·Sector: not specified

26-02-2026

Spok Holdings, Inc. filed an 8-K on February 26, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits, indicating a voluntary release of material non-public information with attached documents. The filing size is 4 MB, suggesting potentially substantial exhibits such as press releases, presentations, or financial data. No specific transaction details, financial metrics, guidance, or events are disclosed in the provided filing information.

26-02-2026

N2OFF, Inc. filed an 8-K on February 26, 2026, disclosing unregistered sales of equity securities under Item 3.02. No transaction value, share count, parties, or financial impacts were mentioned. This is a single-item mandatory filing with no additional metrics provided.

26-02-2026

PUMA BIOTECHNOLOGY, INC. filed a Form 8-K on February 26, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is an informational disclosure of financial results with no quantitative metrics available for analysis.

26-02-2026

TXO Partners, L.P. filed an 8-K on February 26, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing involves voluntary disclosure of potentially material non-public information with attached exhibits. No specific core events, financial metrics, transactions, guidance, or scheduled events are disclosed.

26-02-2026

SBA Communications Corp filed a Form 8-K on 2026-02-26 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing furnishing financial results with attached exhibits (AccNo: 0001193125-26-076767, Size: 609 KB). No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information.

26-02-2026

Abbott Laboratories filed an 8-K on 2026-02-26 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed. This is a mandatory disclosure of a material event without quantified positive or negative elements.

26-02-2026

Concentra Group Holdings Parent, Inc. filed an 8-K on 2026-02-26 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. Detailed performance data including positive, negative, or flat metrics is NOT_DISCLOSED.

26-02-2026

NL Industries Inc filed an 8-K on February 26, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of potentially material non-public information with attached exhibits. No financial metrics, transactions, period-over-period changes, or other quantitative data are disclosed in the filing summary.

26-02-2026

Morgan Stanley Direct Lending Fund filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, or other financial metrics are disclosed in the provided filing description. This multi-item filing appears to be a voluntary disclosure of financial results.

26-02-2026

RED RIVER BANCSHARES INC filed a Form 8-K on February 26, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, with Item 9.01 listing financial statements and exhibits. No specific details on the nature of the amendments, dollar values, strategic rationale, or financial impacts are provided. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons disclosed.

26-02-2026

PPL Corp filed an 8-K on 2026-02-26 reporting entry into a Material Definitive Agreement under Item 1.01, accompanied by Financial Statements and Exhibits under Item 9.01. No details on the agreement parties, terms, value, strategic rationale, financial impacts, or other metrics are disclosed.

26-02-2026

Ready Capital Corp filed a Form 8-K on 2026-02-26 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific financial metrics, period-over-period comparisons, guidance, or performance details (positive, negative, or flat) are disclosed in the provided filing information.

26-02-2026

Federal Signal Corp (/DE/) disclosed an officer change event via 8-K filing on 2026-02-26 under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative impacts are provided.

26-02-2026

TTEC Holdings, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item filing typical for earnings announcements. No specific revenue, earnings, guidance, or period-over-period metrics were detailed in the provided filing information.

26-02-2026

Lamar Advertising Co/NEW filed an 8-K on 2026-02-26 under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transactions, or performance data mentioned.

26-02-2026

BROADWAY FINANCIAL CORP DE filed an 8-K on February 26, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, transactions, financial metrics, or exhibits are disclosed in the filing summary. No quantitative data, comparisons, or directional impacts provided.

26-02-2026

Weyerhaeuser Co filed an 8-K on February 26, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or performance data are disclosed in the filing summary. The filing size is 47 MB, suggesting potential attachments like press releases or presentations.

26-02-2026

CBRE Group, Inc. filed an 8-K on February 26, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on individuals, positions, reasons, or impacts are disclosed.

26-02-2026

Texas Ventures Acquisition III Corp filed an 8-K on 2026-02-26 under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No merger/acquisition details, financial metrics, quantitative data, or sector information are disclosed in the filing summary. No positive or negative performance metrics are mentioned.

26-02-2026

Markel Group Inc. filed an 8-K on 2026-02-26 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), with exhibits under Item 9.01. Specific details on affected positions, individuals involved, reasons for changes, timing, or impacts are NOT_DISCLOSED. No financial metrics, quantitative data, or scheduled events are mentioned.

26-02-2026

Ernexa Therapeutics Inc. filed a Form 8-K on February 26, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. The filing has an accession number 0001493152-26-008182 and a size of 25 MB, indicating attached materials likely related to the disclosure. No quantitative financial metrics, transactions, or performance data are specified.

26-02-2026

Eversource Energy filed an 8-K on February 26, 2026, reporting under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are provided.

26-02-2026

Avery Dennison Corp filed an 8-K on February 26, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the amendments are provided.

26-02-2026

NuScale Power Corp filed an 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed. This is an informational earnings-related filing with no quantitative metrics available.

26-02-2026

MBIA Inc filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-076968, Size: 196 KB), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This multi-item filing pertains to financial results but provides no specific revenue, earnings, balance sheet, or performance metrics. No period-over-period comparisons, guidance, or quantitative impacts are mentioned.

26-02-2026

International Media Acquisition Corp. filed an 8-K on 2026-02-26 under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), disclosing a merger/acquisition-related event. No specific transaction details, parties, values, or metrics were provided in the filing summary. Sector not specified.

26-02-2026

Proficient Auto Logistics, Inc. filed an 8-K on 2026-02-26 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any quantitative impacts are disclosed. No positive or negative metrics are provided, resulting in purely informational disclosure.

26-02-2026

NexMetals Mining Corp. filed a Form 8-K on February 26, 2026 (AccNo: 0001493152-26-008186, size 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information.

26-02-2026

CyberloQ Technologies, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001493152-26-008185), reporting under Item 1.01 entry into a material definitive agreement. No additional details on the nature of the agreement, transaction value, financial impacts, parties involved, or strategic rationale were explicitly stated. No quantitative metrics, positive or negative changes, or comparisons were disclosed.

26-02-2026

Avidity Biosciences, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. No specific details on the matters voted upon, vote results, outcomes, or any quantitative data are disclosed in the provided filing information. This filing is informational in nature with no financial metrics, strategic implications, or directional impacts mentioned.

26-02-2026

Strawberry Fields REIT, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001493152-26-008187, size 223 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed. This is a multi-item informational filing with no quantitative metrics, positive or negative developments mentioned.

26-02-2026

Clipper Realty Inc. filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or quantitative data were mentioned in the filing description. This is a standard financial results announcement without detailed performance indicators.

26-02-2026

Chemours Co filed an 8-K on February 26, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the filing summary provided. No quantitative data, period-over-period comparisons, or directional changes are mentioned.

26-02-2026

Columbus Circle Capital Corp II filed an 8-K on February 26, 2026, disclosing Other Events under Item 8.01 and attaching Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are provided in the filing summary. This is a multi-item, likely voluntary disclosure as Item 8.01 covers events not specified elsewhere.

26-02-2026

Diversified Energy Co filed an 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 7.01 for Regulation FD disclosure. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. No positive, negative, or flat performance data is available for balanced analysis.

26-02-2026

Archrock, Inc. filed a Form 8-K on 2026-02-26 (AccNo: 0001104659-26-020593, Size: 260 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure under SEC rules.

26-02-2026

Eagle Bancorp Montana, Inc. filed an 8-K on 2026-02-26 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are disclosed. Filing size is 154 KB with AccNo 0001437749-26-005899.

• ·AccNo: 0001437749-26-005899
• ·Sector: NOT_DISCLOSED

26-02-2026

ContextLogic Holdings Inc. filed an 8-K on February 26, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), which may provide strategic benefits. However, the filing also reveals creation of a direct financial obligation (Item 2.03) and unregistered sales of equity securities (Item 3.02), introducing potential leverage and dilution risks, alongside changes in directors or officers (Item 5.02). Specific details on parties, deal size, or terms are NOT_DISCLOSED.

26-02-2026

Main Street Capital Corporation filed an 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the filing details provided. This is a multi-item informational filing typical for quarterly financial results announcements.

26-02-2026

Sonida Senior Living, Inc. filed an 8-K on February 26, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting such as an annual meeting. No specific matters, vote outcomes, or quantitative details are disclosed. This is purely informational with no financial or operational metrics provided.

26-02-2026

Skyward Specialty Insurance Group, Inc. filed an 8-K on 2026-02-26 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions affected, reasons for change, timing, or quantitative details are disclosed.

26-02-2026

Arlo Technologies, Inc. filed a Form 8-K on 2026-02-26 (AccNo: 0001736946-26-000029, Size: 622 KB) under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This is a multi-item, standard voluntary earnings release filing. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided information.

26-02-2026

STONERIDGE INC filed a Form 8-K on 2026-02-26 reporting multiple items: Item 1.01 Entry into a Material Definitive Agreement, Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, personnel changes, disclosures, dollar values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item filing with no period-over-period comparisons, guidance, or scheduled events mentioned.

26-02-2026

NewMarket Corp filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-077261, Size: 143 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be an informational filing with no quantified positive or negative impacts mentioned.

26-02-2026

CenterPoint Energy Inc filed an 8-K on February 26, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 references attached financial statements and exhibits. No specific transaction values, financial impacts, positive or negative metrics, or other quantitative details are disclosed.

26-02-2026

Civista Bancshares, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, names, reasons, timing, or any quantitative metrics are disclosed.

26-02-2026

Metropolitan Bank Holding Corp. filed a multi-item Form 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or disclosures are provided in the available metadata. This is an informational filing with no quantified metrics or period-over-period comparisons disclosed.

26-02-2026

Coterra Energy Inc. filed a Form 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics are disclosed in the provided information. No positive or negative performance indicators, transaction values, or strategic details are available.

26-02-2026

Orion S.A. filed a Form 8-K on February 26, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events or contents of the exhibits are disclosed in the filing summary. This is a multi-item informational filing with no quantified financial metrics, transaction values, or performance data provided.

26-02-2026

KB Home filed an 8-K on 2026-02-26 disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also reports other events under Item 8.01 and includes financial statements and exhibits under Item 9.01. No specific details such as names, titles, reasons for changes, timing, financial metrics, or quantitative impacts are disclosed.

26-02-2026

Legato Merger Corp. III filed an 8-K on 2026-02-26 disclosing entry into a Material Definitive Agreement under Item 1.01, likely related to a merger/acquisition, along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific deal structure, parties, valuation, synergies, or financial metrics are disclosed in the provided filing summary. This informational filing signals a significant transaction but lacks details for full assessment.

• ·Filing Accession Number: 0001829126-26-001675
• ·File Size: 919 KB

26-02-2026

Nixxy, Inc. filed an 8-K on 2026-02-26 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, with transfer of listing. No financial metrics, transaction values, or other quantitative data disclosed. Sector not specified.

• ·Accession Number: 0001683168-26-001318
• ·Filing size: 239 KB

26-02-2026

AbbVie Inc. filed an 8-K on February 26, 2026 (AccNo: 0001104659-26-020643, Size: 558 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events or contents of the exhibits are disclosed. This appears to be a multi-item informational filing with no quantitative metrics, positive or negative performance indicators, or directional implications provided.

26-02-2026

RLJ Lodging Trust filed an 8-K on 2026-02-26 reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing metadata. This is a standard multi-item earnings-related disclosure without detailed performance data.

26-02-2026

Boston Scientific Corp filed a multi-item 8-K on February 26, 2026, disclosing entry into a material definitive agreement (Item 1.01) while terminating a prior material definitive agreement (Item 1.02). The filing also reports the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits under Item 9.01. No specific transaction values, parties, terms, or financial impacts are disclosed.

26-02-2026

Technology & Telecommunication Acquisition Corp filed an 8-K on 2026-02-26 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. The filing also covers amendments to articles of incorporation or bylaws and potential change in fiscal year under Item 5.03, as well as submission of matters to a vote of security holders under Item 5.07, with financial statements and exhibits under Item 9.01. No specific transaction parties, terms, valuations, synergies, or financial metrics are disclosed.

26-02-2026

WHITE MOUNTAINS INSURANCE GROUP LTD filed an 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any financial statements or exhibits are disclosed in the provided filing summary. This appears to be a multi-item informational filing with no quantified metrics or directional impacts mentioned.

• ·Filing Accession Number: 0001628280-26-012417
• ·Filing Size: 162 KB
• ·Multi-item 8-K: Items 8.01 and 9.01

26-02-2026

Propanc Biopharma, Inc. filed an 8-K on 2026-02-26 disclosing an officer or director change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, names, appointment or resignation status, reasons, timing, or compensation are disclosed.

26-02-2026

CORPAY, INC. filed an 8-K on 2026-02-26 reporting Item 5.08 regarding shareholder nominations pursuant to Exchange Act Rule 14a-11 and Item 8.01 other events. No financial metrics, transaction values, or quantitative data were disclosed in the filing summary. This appears to be an informational disclosure without specified positive or negative impacts.

26-02-2026

NKGen Biotech, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits, likely including the agreement. No quantitative details, financial impacts, positive or negative metrics, or further context on the transaction are provided.

26-02-2026

Liberty Media Corp filed an 8-K on February 26, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings release announcement without detailed metrics available.

26-02-2026

CNX Resources Corp filed an 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, financial metrics, or performance comparisons (positive, negative, or flat) were disclosed in the filing summary. This multi-item filing indicates significant corporate actions but lacks quantitative data for impact assessment.

26-02-2026

Jacobs Solutions Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-077417, Size: 425 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item informational disclosure without quantified positive or negative impacts.

• ·Filing size: 425 KB (suggests exhibits present)

26-02-2026

Rocket Companies, Inc. filed a Form 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item filing with no specific revenue, earnings, or other metrics disclosed in the provided information. No positive or negative performance indicators, guidance, or comparisons are mentioned.

26-02-2026

Vir Biotechnology, Inc. filed an 8-K on 2026-02-26 disclosing entry into a material definitive agreement under Item 1.01, with exhibits under Item 9.01 (AccNo: 0001193125-26-077416, file size 442 KB). No specific details on the agreement terms, transaction value, financial impacts, or strategic rationale are provided. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.

• ·File size: 442 KB
• ·Sector: not specified

26-02-2026

Macerich Co filed an 8-K on 2026-02-26 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No quantitative details such as transaction values, financial impacts, or comparisons are disclosed.

26-02-2026

Palvella Therapeutics, Inc. filed an 8-K on 2026-02-26 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are disclosed.

• ·Filing Accession Number: 0001104659-26-020667
• ·File Size: 584 KB
• ·Event Date: 2026-02-26
• ·Sector: not specified
• ·Multi-item 8-K filing (Items 1.01 and 9.01)
• ·Mandatory disclosure under Item 1.01 for material agreements

26-02-2026

FTAI Infrastructure Inc. filed an 8-K on 2026-02-26 disclosing entry into a material definitive agreement under Item 1.01 and termination of a material definitive agreement under Item 1.02. The filing also includes results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, or quantitative impacts are disclosed.